இனம் புற்றுநோயியல் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இனம் புற்றுநோயியல் லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இனம் புற்றுநோயியல் லிமிடெட் Today - Breaking & Trending Today

Why the Race Oncology (ASX:RAC) share price is racing higher


Why the Race Oncology (ASX:RAC) share price is racing higher
Ken Hall | April 28, 2021 10:49am |
More on:
The 
Race Oncology Ltd (ASX: RAC) share price is climbing today after an update from the Aussie healthcare company.
Why is the Race Oncology share price climbing?
Race Oncology announced that it has entered into a collaborative preclinical research program with The University of Newcastle. The purpose of the program is to investigate the heart safety Bisantrene offers over current anthracycline therapeutics. 
Bisantrene is Race Oncology’s Phase 2/3 cancer drug that is a “potent inhibitor” of the Fatso/Fat mass and obesity-associated (FTO) protein. The possible role of FTO inhibition in Bisantrene’s lack of cardiotoxicity will be a primary focus of the new project. ....

Daniel Tillett , Aaron Sverdlov , Scott Phillips , Doan Ngo , Race Oncology Ltd , University Of Newcastle , Race Oncology , Three Pillar , Scientific Officer Dr Daniel Tillett , Motley Fool Share Advisor , டேனியல் டிலெட் , ஸ்காட் பிலிப்ஸ் , டோந் ங்கோ , இனம் புற்றுநோயியல் லிமிடெட் , பல்கலைக்கழகம் ஆஃப் நியூகேஸில் , இனம் புற்றுநோயியல் , மூன்று தூண் ,

What sent the Race Oncology (ASX:RAC) share price rocketing 20% today?


The
Race Oncology Ltd(ASX: RAC) share price rocketed 20.98% today, closing the day at $2.48 per share.
Race Oncology Ltd (RAC) is an Australian pharmaceutical company with developments in the cancer field. The company produces a chemotherapy drug called Bisantrene, which has been the subject of more than 40 phase II clinical studies.
Today’s gains cap off a big week for the Race Oncology share price, which has boosted more than 45% in the past 5 days.
While there was no news out of Race Oncology today, its quarterly report was released on 27 January 2021. We take a closer look at the company’s recent performance.  ....

Scott Phillips , Phillip Lynch , Race Oncology Ltd , Oncology Ltd , Race Oncology , Three Pillar , Annual General , Motley Fool Share Advisor , ஸ்காட் பிலிப்ஸ் , பிலிப் லிஞ்ச் , இனம் புற்றுநோயியல் லிமிடெட் , புற்றுநோயியல் லிமிடெட் , இனம் புற்றுநோயியல் , மூன்று தூண் , ஆண்டு ஜநரல் ,